{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:44:44Z","timestamp":1790840684033,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","doi-asserted-by":"crossref","award":["81571139"],"award-info":[{"award-number":["81571139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National\u00a0Natural\u00a0Science\u00a0Foundation\u00a0of\u00a0China","doi-asserted-by":"crossref","award":["81571119"],"award-info":[{"award-number":["81571119"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2018YFC1312200"],"award-info":[{"award-number":["2018YFC1312200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00018-018-2937-2","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T23:44:10Z","timestamp":1539042250000},"page":"341-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["The role of P2Y12 receptor in ischemic stroke of atherosclerotic origin"],"prefix":"10.1007","volume":"76","author":[{"given":"Ying","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulan","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"issue":"1","key":"2937_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24(1):35\u201341","journal-title":"Stroke"},{"issue":"4","key":"2937_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","volume":"16","author":"P Amarenco","year":"2017","unstructured":"Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC, Committee SS, Investigators (2017) Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol 16(4):301\u2013310. https:\/\/doi.org\/10.1016\/S1474-4422(17)30038-8","journal-title":"Lancet Neurol"},{"issue":"5\u20136","key":"2937_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/09537109609023587","volume":"7","author":"C Gachet","year":"1996","unstructured":"Gachet C, Hechler B, L\u00e9on C, Vial C, Ohlmann P, Cazenave JP (1996) Purinergic receptors on blood platelets. Platelets 7(5\u20136):261\u2013267. https:\/\/doi.org\/10.3109\/09537109609023587","journal-title":"Platelets"},{"issue":"6817","key":"2937_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/35051599","volume":"409","author":"G Hollopeter","year":"2001","unstructured":"Hollopeter G, Jantzen HM, Vincent D, Li G, England L, Ramakrishnan V, Yang RB, Nurden P, Nurden A, Julius D, Conley PB (2001) Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature 409(6817):202\u2013207. https:\/\/doi.org\/10.1038\/35051599","journal-title":"Nature"},{"issue":"2","key":"2937_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-2003-40669","volume":"3","author":"J-M Herbert","year":"2003","unstructured":"Herbert J-M, Savi P (2003) P2Y12, a new platelet ADP receptor, target of clopidogrel. Semin Vasc Med 3(2):113\u2013122. https:\/\/doi.org\/10.1055\/s-2003-40669","journal-title":"Semin Vasc Med"},{"issue":"3","key":"2937_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0026-895X(24)12604-1","volume":"60","author":"J Takasaki","year":"2001","unstructured":"Takasaki J, Kamohara M, Saito T, Matsumoto M, Matsumoto S, Ohishi T, Soga T, Matsushime H, Furuichi K (2001) Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor. Mol Pharmacol 60(3):432\u2013439","journal-title":"Mol Pharmacol"},{"issue":"12","key":"2937_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1172\/JCI12242","volume":"107","author":"CJ Foster","year":"2001","unstructured":"Foster CJ, Prosser DM, Agans JM, Zhai Y, Smith MD, Lachowicz JE, Zhang FL, Gustafson E, Monsma FJ Jr, Wiekowski MT, Abbondanzo SJ, Cook DN, Bayne ML, Lira SA, Chintala MS (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107(12):1591\u20131598. https:\/\/doi.org\/10.1172\/JCI12242","journal-title":"J Clin Invest"},{"issue":"11","key":"2937_CR8","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V80.11.2787.2787","volume":"80","author":"M Cattaneo","year":"1992","unstructured":"Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM (1992) Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 80(11):2787\u20132796","journal-title":"Blood"},{"issue":"3","key":"2937_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11302-012-9303-x","volume":"8","author":"C Gachet","year":"2012","unstructured":"Gachet C (2012) P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells. Purinergic Signal 8(3):609\u2013619. https:\/\/doi.org\/10.1007\/s11302-012-9303-x","journal-title":"Purinergic Signal"},{"issue":"4\u20135","key":"2937_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s002100000311","volume":"362","author":"W Norenberg","year":"2000","unstructured":"Norenberg W, Illes P (2000) Neuronal P2X receptors: localisation and functional properties. Naunyn Schmiedebergs Arch Pharmacol 362(4\u20135):324\u2013339","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"2937_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1124\/pr.58.3.3","volume":"58","author":"MP Abbracchio","year":"2006","unstructured":"Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3):281\u2013341. https:\/\/doi.org\/10.1124\/pr.58.3.3","journal-title":"Pharmacol Rev"},{"issue":"4\u20135","key":"2937_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s002100000310","volume":"362","author":"I Kugelgen von","year":"2000","unstructured":"von Kugelgen I, Wetter A (2000) Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362(4\u20135):310\u2013323","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"2937_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0165-6147(02)00038-X","volume":"24","author":"MP Abbracchio","year":"2003","unstructured":"Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24(2):52\u201355. https:\/\/doi.org\/10.1016\/S0165-6147(02)00038-X","journal-title":"Trends Pharmacol Sci"},{"issue":"7498","key":"2937_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature13083","volume":"509","author":"K Zhang","year":"2014","unstructured":"Zhang K, Zhang J, Gao ZG, Zhang D, Zhu L, Han GW, Moss SM, Paoletta S, Kiselev E, Lu W, Fenalti G, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q (2014) Structure of the human P2Y12 receptor in complex with an antithrombotic drug. Nature 509(7498):115\u2013118. https:\/\/doi.org\/10.1038\/nature13083","journal-title":"Nature"},{"issue":"7498","key":"2937_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature13288","volume":"509","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang K, Gao ZG, Paoletta S, Zhang D, Han GW, Li T, Ma L, Zhang W, Muller CE, Yang H, Jiang H, Cherezov V, Katritch V, Jacobson KA, Stevens RC, Wu B, Zhao Q (2014) Agonist-bound structure of the human P2Y12 receptor. Nature 509(7498):119\u2013122. https:\/\/doi.org\/10.1038\/nature13288","journal-title":"Nature"},{"issue":"29","key":"2937_CR16","doi-asserted-by":"publisher","first-page":"11069","DOI":"10.1073\/pnas.0510446103","volume":"103","author":"P Savi","year":"2006","unstructured":"Savi P, Zachayus JL, Delesque-Touchard N, Labouret C, Herve C, Uzabiaga MF, Pereillo JM, Culouscou JM, Bono F, Ferrara P, Herbert JM (2006) The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc Natl Acad Sci USA 103(29):11069\u201311074. https:\/\/doi.org\/10.1073\/pnas.0510446103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2937_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1538-7836.2008.03202.x","volume":"7","author":"Z Ding","year":"2009","unstructured":"Ding Z, Bynagari YS, Mada SR, Jakubowski JA, Kunapuli SP (2009) Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12 receptor when interacting with antagonists. J Thromb Haemost 7(1):232\u2013234. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03202.x","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2937_CR18","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1074\/jbc.M009718200","volume":"276","author":"FL Zhang","year":"2001","unstructured":"Zhang FL, Luo L, Gustafson E, Lachowicz J, Smith M, Qiao X, Liu YH, Chen G, Pramanik B, Laz TM, Palmer K, Bayne M, Monsma FJ Jr (2001) ADP is the cognate ligand for the orphan G protein-coupled receptor SP1999. J Biol Chem 276(11):8608\u20138615. https:\/\/doi.org\/10.1074\/jbc.M009718200","journal-title":"J Biol Chem"},{"issue":"10","key":"2937_CR19","doi-asserted-by":"publisher","first-page":"e26035","DOI":"10.1371\/journal.pone.0026035","volume":"6","author":"AE Garcia","year":"2011","unstructured":"Garcia AE, Mada SR, Rico MC, Dela Cadena RA, Kunapuli SP (2011) Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis. PLoS One 6(10):e26035. https:\/\/doi.org\/10.1371\/journal.pone.0026035","journal-title":"PLoS One"},{"issue":"11","key":"2937_CR20","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1538-7836.2004.00926.x","volume":"2","author":"G Kauffenstein","year":"2004","unstructured":"Kauffenstein G, Hechler B, Cazenave JP, Gachet C (2004) Adenine triphosphate nucleotides are antagonists at the P2Y receptor. J Thromb Haemost 2(11):1980\u20131988. https:\/\/doi.org\/10.1111\/j.1538-7836.2004.00926.x","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2937_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/sj.bjp.0702690","volume":"127","author":"HS Park","year":"1999","unstructured":"Park HS, Hourani SM (1999) Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets. Br J Pharmacol 127(6):1359\u20131366. https:\/\/doi.org\/10.1038\/sj.bjp.0702690","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2937_CR22","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1212\/NXI.0000000000000080","volume":"2","author":"CS Moore","year":"2015","unstructured":"Moore CS, Ase AR, Kinsara A, Rao VT, Michell-Robinson M, Leong SY, Butovsky O, Ludwin SK, Seguela P, Bar-Or A, Antel JP (2015) P2Y12 expression and function in alternatively activated human microglia. Neurol Neuroimmunol Neuroinflamm 2(2):e80. https:\/\/doi.org\/10.1212\/NXI.0000000000000080","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"2937_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/jcbfm.2014.45","volume":"34","author":"P Gelosa","year":"2014","unstructured":"Gelosa P, Lecca D, Fumagalli M, Wypych D, Pignieri A, Cimino M, Verderio C, Enerback M, Nikookhesal E, Tremoli E, Abbracchio MP, Sironi L (2014) Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor. J Cereb Blood Flow Metab 34(6):979\u2013988. https:\/\/doi.org\/10.1038\/jcbfm.2014.45","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"2937_CR24","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.4049\/jimmunol.0901799","volume":"185","author":"A Ben Addi","year":"2010","unstructured":"Ben Addi A, Cammarata D, Conley PB, Boeynaems JM, Robaye B (2010) Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 185(10):5900\u20135906. https:\/\/doi.org\/10.4049\/jimmunol.0901799","journal-title":"J Immunol"},{"issue":"6","key":"2937_CR25","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/cercor\/bhp193","volume":"20","author":"S Amadio","year":"2010","unstructured":"Amadio S, Montilli C, Magliozzi R, Bernardi G, Reynolds R, Volonte C (2010) P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb Cortex 20(6):1263\u20131273. https:\/\/doi.org\/10.1093\/cercor\/bhp193 (New York, NY: 1991)","journal-title":"Cereb Cortex"},{"issue":"2","key":"2937_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/glia.20160","volume":"50","author":"C Agresti","year":"2005","unstructured":"Agresti C, Meomartini ME, Amadio S, Ambrosini E, Serafini B, Franchini L, Volonte C, Aloisi F, Visentin S (2005) Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development. Glia 50(2):132\u2013144. https:\/\/doi.org\/10.1002\/glia.20160","journal-title":"Glia"},{"issue":"6","key":"2937_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/sj.bjp.0704353","volume":"134","author":"H Franke","year":"2001","unstructured":"Franke H, Krugel U, Schmidt R, Grosche J, Reichenbach A, Illes P (2001) P2 receptor-types involved in astrogliosis in vivo. Br J Pharmacol 134(6):1180\u20131189. https:\/\/doi.org\/10.1038\/sj.bjp.0704353","journal-title":"Br J Pharmacol"},{"issue":"35","key":"2937_CR28","doi-asserted-by":"publisher","first-page":"31390","DOI":"10.1074\/jbc.M110714200","volume":"277","author":"J Simon","year":"2002","unstructured":"Simon J, Filippov AK, Goransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277(35):31390\u201331400. https:\/\/doi.org\/10.1074\/jbc.M110714200","journal-title":"J Biol Chem"},{"issue":"1","key":"2937_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/ATVBAHA.111.238063","volume":"32","author":"C Cavelier","year":"2012","unstructured":"Cavelier C, Ohnsorg PM, Rohrer L, von Eckardstein A (2012) The beta-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells. Arterioscler Thromb Vasc Biol 32(1):131\u2013139. https:\/\/doi.org\/10.1161\/ATVBAHA.111.238063","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2937_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11239-006-9033-4","volume":"22","author":"G Shanker","year":"2006","unstructured":"Shanker G, Kontos JL, Eckman DM, Wesley-Farrington D, Sane DC (2006) Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis 22(3):213\u2013220. https:\/\/doi.org\/10.1007\/s11239-006-9033-4","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"2937_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijcard.2008.12.091","volume":"142","author":"C Hogberg","year":"2010","unstructured":"Hogberg C, Svensson H, Gustafsson R, Eyjolfsson A, Erlinge D (2010) The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature. Int J Cardiol 142(2):187\u2013192. https:\/\/doi.org\/10.1016\/j.ijcard.2008.12.091","journal-title":"Int J Cardiol"},{"issue":"10","key":"2937_CR32","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","volume":"24","author":"A-K Wihlborg","year":"2004","unstructured":"Wihlborg A-K, Wang L, Braun OO, Eyjolfsson A, Gustafsson R, Gudbjartsson T, Erlinge D (2004) ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arterioscler Thromb Vasc Biol 24(10):1810\u20131815. https:\/\/doi.org\/10.1161\/01.ATV.0000142376.30582.ed","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"2937_CR33","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1172\/JCI38576","volume":"122","author":"X Su","year":"2012","unstructured":"Su X, Floyd DH, Hughes A, Xiang J, Schneider JG, Uluckan O, Heller E, Deng H, Zou W, Craft CS, Wu K, Hirbe AC, Grabowska D, Eagleton MC, Townsley S, Collins L, Piwnica-Worms D, Steinberg TH, Novack DV, Conley PB, Hurchla MA, Rogers M, Weilbaecher KN (2012) The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest 122(10):3579\u20133592. https:\/\/doi.org\/10.1172\/JCI38576","journal-title":"J Clin Invest"},{"issue":"132","key":"2937_CR34","doi-asserted-by":"publisher","first-page":"ra55","DOI":"10.1126\/scisignal.2000588","volume":"3","author":"M Kronlage","year":"2010","unstructured":"Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T, Leipziger J, Robaye B, Conley PB, Kim HC, Sargin S, Schon P, Schwab A, Hanley PJ (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3(132):ra55. https:\/\/doi.org\/10.1126\/scisignal.2000588","journal-title":"Sci Signal"},{"issue":"52","key":"2937_CR35","doi-asserted-by":"publisher","first-page":"44776","DOI":"10.1074\/jbc.M111.289793","volume":"286","author":"K Isfort","year":"2011","unstructured":"Isfort K, Ebert F, Bornhorst J, Sargin S, Kardakaris R, Pasparakis M, Bahler M, Schwerdtle T, Schwab A, Hanley PJ (2011) Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent. J Biol Chem 286(52):44776\u201344787. https:\/\/doi.org\/10.1074\/jbc.M111.289793","journal-title":"J Biol Chem"},{"issue":"3","key":"2937_CR36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","volume":"105","author":"P Diehl","year":"2010","unstructured":"Diehl P, Olivier C, Halscheid C, Helbing T, Bode C, Moser M (2010) Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes. Basic Res Cardiol 105(3):379\u2013387. https:\/\/doi.org\/10.1007\/s00395-009-0073-8","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"2937_CR37","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1182\/blood-2010-08-263111","volume":"117","author":"M Cattaneo","year":"2011","unstructured":"Cattaneo M (2011) The platelet P2Y(1)(2) receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 117(7):2102\u20132112. https:\/\/doi.org\/10.1182\/blood-2010-08-263111","journal-title":"Blood"},{"issue":"2","key":"2937_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1160\/TH13-11-0915","volume":"112","author":"P Adamski","year":"2014","unstructured":"Adamski P, Kozinski M, Ostrowska M, Fabiszak T, Navarese EP, Paciorek P, Grzesk G, Kubica J (2014) Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors. Thromb Haemost 112(2):224\u2013242. https:\/\/doi.org\/10.1160\/TH13-11-0915","journal-title":"Thromb Haemost"},{"issue":"2","key":"2937_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1055\/s-2005-869523","volume":"31","author":"P Savi","year":"2005","unstructured":"Savi P, Herbert JM (2005) Clopidogrel and ticlopidine: p2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. Semin Thromb Hemost 31(2):174\u2013183. https:\/\/doi.org\/10.1055\/s-2005-869523","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"2937_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1603060","volume":"375","author":"SC Johnston","year":"2016","unstructured":"Johnston SC, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KS, Committee SS, Investigators (2016) Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med 375(1):35\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1603060","journal-title":"N Engl J Med"},{"issue":"9038","key":"2937_CR41","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CS Committee","year":"1996","unstructured":"Committee CS (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038):1329\u20131339","journal-title":"Lancet"},{"issue":"2","key":"2937_CR42","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1161\/01.str.0000110221.54366.49","volume":"35","author":"PA Ringleb","year":"2004","unstructured":"Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W (2004) Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events. Stroke 35(2):528\u2013532. https:\/\/doi.org\/10.1161\/01.str.0000110221.54366.49","journal-title":"Stroke"},{"issue":"19","key":"2937_CR43","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","volume":"49","author":"DL Bhatt","year":"2007","unstructured":"Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA (2007) Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol 49(19):1982\u20131988. https:\/\/doi.org\/10.1016\/j.jacc.2007.03.025","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2937_CR44","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/STROKEAHA.115.012293","volume":"47","author":"KS Hong","year":"2016","unstructured":"Hong KS, Lee SH, Kim EG, Cho KH, Chang DI, Rha JH, Bae HJ, Lee KB, Kim DE, Park JM, Kim HY, Cha JK, Yu KH, Lee YS, Lee SJ, Choi JC, Cho YJ, Kwon SU, Kim GM, Sohn SI, Park KY, Kang DW, Sohn CH, Lee J, Yoon BW, Investigators C (2016) Recurrent ischemic lesions after acute atherothrombotic stroke: clopidogrel plus aspirin versus aspirin alone. Stroke 47(9):2323\u20132330. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012293","journal-title":"Stroke"},{"issue":"13","key":"2937_CR45","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1212\/wnl.0000000000001972","volume":"85","author":"L Liu","year":"2015","unstructured":"Liu L, Wong KS, Leng X, Pu Y, Wang Y, Jing J, Zou X, Pan Y, Wang A, Meng X, Wang C, Zhao X, Soo Y, Johnston SC, Wang Y (2015) Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE. Neurology 85(13):1154\u20131162. https:\/\/doi.org\/10.1212\/wnl.0000000000001972","journal-title":"Neurology"},{"issue":"8","key":"2937_CR46","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/0091270009355161","volume":"50","author":"M Man","year":"2010","unstructured":"Man M, Farmen M, Dumaual C, Teng CH, Moser B, Irie S, Noh GJ, Njau R, Close S, Wise S, Hockett R (2010) Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans. J Clin Pharmacol 50(8):929\u2013940. https:\/\/doi.org\/10.1177\/0091270009355161","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"2937_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11596-015-1404-7","volume":"35","author":"X Niu","year":"2015","unstructured":"Niu X, Mao L, Huang Y, Baral S, Li JY, Gao Y, Xia YP, He QW, Wang MD, Li M, Zou L, Miao XP, Hu B (2015) CYP2C19 polymorphism and clinical outcomes among patients of different races treated with clopidogrel: a systematic review and meta-analysis. J Huazhong Univ Sci Technol Med Sci 35(2):147\u2013156. https:\/\/doi.org\/10.1007\/s11596-015-1404-7","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"1","key":"2937_CR48","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jama.2016.8662","volume":"316","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao X, Lin J, Li H, Johnston SC, Lin Y, Pan Y, Liu L, Wang D, Wang C, Meng X, Xu J, Wang Y (2016) Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack. JAMA 316(1):70\u201378. https:\/\/doi.org\/10.1001\/jama.2016.8662","journal-title":"JAMA"},{"issue":"8","key":"2937_CR49","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1161\/ATVBAHA.111.239095","volume":"32","author":"D Li","year":"2012","unstructured":"Li D, Wang Y, Zhang L, Luo X, Li J, Chen X, Niu H, Wang K, Sun Y, Wang X, Yan Y, Chai W, Gartner TK, Liu J (2012) Roles of purinergic receptor P2Y, G protein-coupled 12 in the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 32(8):e81\u2013e89. https:\/\/doi.org\/10.1161\/ATVBAHA.111.239095","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2937_CR50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/cvr\/cvu028","volume":"102","author":"LE West","year":"2014","unstructured":"West LE, Steiner T, Judge HM, Francis SE, Storey RF (2014) Vessel wall, not platelet, P2Y12 potentiates early atherogenesis. Cardiovasc Res 102(3):429\u2013435. https:\/\/doi.org\/10.1093\/cvr\/cvu028","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2937_CR51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0008-6363(98)00276-4","volume":"41","author":"AC Wal van der","year":"1999","unstructured":"van der Wal AC, Becker AE (1999) Atherosclerotic plaque rupture\u2013pathologic basis of plaque stability and instability. Cardiovasc Res 41(2):334\u2013344","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2937_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1161\/atvbaha.115.306347","volume":"36","author":"Y Boulaftali","year":"2016","unstructured":"Boulaftali Y, Owens AP 3rd, Beale A, Piatt R, Casari C, Lee RH, Conley PB, Paul DS, Mackman N, Bergmeier W (2016) CalDAG-GEFI deficiency reduces atherosclerotic lesion development in mice. Arterioscler Thromb Vasc Biol 36(5):792\u2013799. https:\/\/doi.org\/10.1161\/atvbaha.115.306347","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2937_CR53","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1097\/TP.0b013e318196305a","volume":"87","author":"K Yashiro","year":"2009","unstructured":"Yashiro K, Matsumoto Y, Ihara H, Suzuki Y, Kondo K, Urano E, Umemura K (2009) Involvement of platelet activation by P2Y receptor in the development of transplant arteriosclerosis in mice. Transplantation 87(5):660\u2013667. https:\/\/doi.org\/10.1097\/TP.0b013e318196305a","journal-title":"Transplantation"},{"issue":"2","key":"2937_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/TP.0b013e318221d407","volume":"92","author":"K Harada","year":"2011","unstructured":"Harada K, Matsumoto Y, Umemura K (2011) Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis. Transplantation 92(2):148\u2013154. https:\/\/doi.org\/10.1097\/TP.0b013e318221d407","journal-title":"Transplantation"},{"issue":"3","key":"2937_CR55","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.mvr.2009.01.009","volume":"77","author":"AKE Afek","year":"2009","unstructured":"Afek AKE, Maysel-Auslender S, Mor A, Regev E, Rubinstein A, Keren G, George J (2009) Clopidogrel attenuates atheroma formation and induces a stable plaque phenotype in apolipoprotein E knockout mice. Microvasc Res 77(3):364\u2013369","journal-title":"Microvasc Res"},{"issue":"3","key":"2937_CR56","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/atvbaha.116.308725","volume":"37","author":"X Niu","year":"2017","unstructured":"Niu X, Pi SL, Baral S, Xia YP, He QW, Li YN, Jin HJ, Li M, Wang MD, Mao L, Hu B (2017) P2Y12 promotes migration of vascular smooth muscle cells through cofilin dephosphorylation during atherogenesis. Arterioscler Thromb Vasc Biol 37(3):515\u2013524. https:\/\/doi.org\/10.1161\/atvbaha.116.308725","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2937_CR57","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10554-011-9910-6","volume":"28","author":"M Takeda","year":"2012","unstructured":"Takeda M, Yamashita T, Shinohara M, Sasaki N, Tawa H, Nakajima K, Momose A, Hirata K (2012) Beneficial effect of anti-platelet therapies on atherosclerotic lesion formation assessed by phase-contrast X-ray CT imaging. Int J Cardiovasc Imaging 28(5):1181\u20131191. https:\/\/doi.org\/10.1007\/s10554-011-9910-6","journal-title":"Int J Cardiovasc Imaging"},{"issue":"5","key":"2937_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00380-015-0696-7","volume":"31","author":"C Heim","year":"2016","unstructured":"Heim C, Gebhardt J, Ramsperger-Gleixner M, Jacobi J, Weyand M, Ensminger SM (2016) Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo. Heart Vessels 31(5):783\u2013794. https:\/\/doi.org\/10.1007\/s00380-015-0696-7","journal-title":"Heart Vessels"},{"key":"2937_CR59","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2147\/DDDT.S105718","volume":"10","author":"MR Preusch","year":"2016","unstructured":"Preusch MR, Rusnak J, Staudacher K, Mogler C, Uhlmann L, Sievers P, Bea F, Katus HA, Blessing E, Staudacher I (2016) Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis. Drug Des Devel Ther 10:2691\u20132699. https:\/\/doi.org\/10.2147\/DDDT.S105718","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"2937_CR60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2006.11.006","volume":"194","author":"M Li","year":"2007","unstructured":"Li M, Zhang YJ, Ren HS, Zhang YC, Zhu XL (2007) Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. Atherosclerosis 194(2):348\u2013356. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.11.006","journal-title":"Atherosclerosis"},{"issue":"1","key":"2937_CR61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.atv.0000150649.39934.13","volume":"25","author":"NR Madamanchi","year":"2005","unstructured":"Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25(1):29\u201338. https:\/\/doi.org\/10.1161\/01.atv.0000150649.39934.13","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"2937_CR62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1161\/circulationaha.116.026995","volume":"136","author":"L Hu","year":"2017","unstructured":"Hu L, Chang L, Zhang Y, Zhai L, Zhang S, Qi Z, Yan H, Yan Y, Luo X, Zhang S, Wang Y, Kunapuli SP, Ye H, Ding Z (2017) Platelets express activated P2Y12 receptor in patients with diabetes mellitus. Circulation 136(9):817\u2013833. https:\/\/doi.org\/10.1161\/circulationaha.116.026995","journal-title":"Circulation"},{"issue":"4","key":"2937_CR63","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1055\/s-0037-1614384","volume":"82","author":"JL Daniel","year":"1999","unstructured":"Daniel JL, Dangelmaier C, Jin J, Kim YB, Kunapuli SP (1999) Role of intracellular signaling events in ADP-induced platelet aggregation. Thromb Haemost 82(4):1322\u20131326","journal-title":"Thromb Haemost"},{"issue":"4","key":"2937_CR64","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/09537109976086","volume":"10","author":"AA Weber","year":"1999","unstructured":"Weber AA, Hohlfeld T, Schror K (1999) cAMP is an important messenger for ADP-induced platelet aggregation. Platelets 10(4):238\u2013241. https:\/\/doi.org\/10.1080\/09537109976086","journal-title":"Platelets"},{"issue":"12","key":"2937_CR65","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1172\/JCI27196","volume":"115","author":"M Gawaz","year":"2005","unstructured":"Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Invest 115(12):3378\u20133384. https:\/\/doi.org\/10.1172\/JCI27196","journal-title":"J Clin Invest"},{"issue":"12","key":"2937_CR66","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood.V94.12.4156","volume":"94","author":"C Trumel","year":"1999","unstructured":"Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson EA, Cazenave JP, Chap H, Gachet C (1999) A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94(12):4156\u20134165","journal-title":"Blood"},{"issue":"5","key":"2937_CR67","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1182\/blood-2008-02-139733","volume":"112","author":"SM Cifuni","year":"2008","unstructured":"Cifuni SM, Wagner DD, Bergmeier W (2008) CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood 112(5):1696\u20131703. https:\/\/doi.org\/10.1182\/blood-2008-02-139733","journal-title":"Blood"},{"issue":"4","key":"2937_CR68","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3109\/09537101003639931","volume":"21","author":"L Stefanini","year":"2010","unstructured":"Stefanini L, Bergmeier W (2010) CalDAG-GEFI and platelet activation. Platelets 21(4):239\u2013243. https:\/\/doi.org\/10.3109\/09537101003639931","journal-title":"Platelets"},{"issue":"14","key":"2937_CR69","doi-asserted-by":"publisher","first-page":"12009","DOI":"10.1074\/jbc.M111803200","volume":"277","author":"P Lova","year":"2002","unstructured":"Lova P, Paganini S, Sinigaglia F, Balduini C, Torti M (2002) A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 277(14):12009\u201312015. https:\/\/doi.org\/10.1074\/jbc.M111803200","journal-title":"J Biol Chem"},{"issue":"26","key":"2937_CR70","doi-asserted-by":"publisher","first-page":"23382","DOI":"10.1074\/jbc.M202212200","volume":"277","author":"D Woulfe","year":"2002","unstructured":"Woulfe D, Jiang H, Mortensen R, Yang J, Brass LF (2002) Activation of Rap1B by G(i) family members in platelets. J Biol Chem 277(26):23382\u201323390. https:\/\/doi.org\/10.1074\/jbc.M202212200","journal-title":"J Biol Chem"},{"issue":"8","key":"2937_CR71","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1538-7836.2008.03041.x","volume":"6","author":"JM Cosemans","year":"2008","unstructured":"Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW (2008) Multiple ways to switch platelet integrins on and off. J Thromb Haemost 6(8):1253\u20131261. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03041.x","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2937_CR72","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1096\/fj.00-0810fje","volume":"15","author":"E Hirsch","year":"2001","unstructured":"Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15(11):2019\u20132021. https:\/\/doi.org\/10.1096\/fj.00-0810fje","journal-title":"FASEB J"},{"issue":"10","key":"2937_CR73","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2009-03-208074","volume":"114","author":"I Canobbio","year":"2009","unstructured":"Canobbio I, Stefanini L, Cipolla L, Ciraolo E, Gruppi C, Balduini C, Hirsch E, Torti M (2009) Genetic evidence for a predominant role of PI3Kbeta catalytic activity in ITAM- and integrin-mediated signaling in platelets. Blood 114(10):2193\u20132196. https:\/\/doi.org\/10.1182\/blood-2009-03-208074","journal-title":"Blood"},{"issue":"39","key":"2937_CR74","doi-asserted-by":"publisher","first-page":"28648","DOI":"10.1074\/jbc.M704358200","volume":"282","author":"SM Schoenwaelder","year":"2007","unstructured":"Schoenwaelder SM, Ono A, Sturgeon S, Chan SM, Mangin P, Maxwell MJ, Turnbull S, Mulchandani M, Anderson K, Kauffenstein G, Rewcastle GW, Kendall J, Gachet C, Salem HH, Jackson SP (2007) Identification of a unique co-operative phosphoinositide 3-kinase signaling mechanism regulating integrin alpha IIb beta 3 adhesive function in platelets. J Biol Chem 282(39):28648\u201328658. https:\/\/doi.org\/10.1074\/jbc.M704358200","journal-title":"J Biol Chem"},{"issue":"4","key":"2937_CR75","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1172\/jci77993","volume":"125","author":"L Stefanini","year":"2015","unstructured":"Stefanini L, Paul DS, Robledo RF, Chan ER, Getz TM, Campbell RA, Kechele DO, Casari C, Piatt R, Caron KM, Mackman N, Weyrich AS, Parrott MC, Boulaftali Y, Adams MD, Peters LL, Bergmeier W (2015) RASA3 is a critical inhibitor of RAP1-dependent platelet activation. J Clin Invest 125(4):1419\u20131432. https:\/\/doi.org\/10.1172\/jci77993","journal-title":"J Clin Invest"},{"issue":"1","key":"2937_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00109-015-1346-3","volume":"94","author":"L Stefanini","year":"2016","unstructured":"Stefanini L, Bergmeier W (2016) RAP1-GTPase signaling and platelet function. J Mol Med 94(1):13\u201319. https:\/\/doi.org\/10.1007\/s00109-015-1346-3","journal-title":"J Mol Med"},{"issue":"2","key":"2937_CR77","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1042\/bj20100166","volume":"429","author":"A Garcia","year":"2010","unstructured":"Garcia A, Kim S, Bhavaraju K, Schoenwaelder SM, Kunapuli SP (2010) Role of phosphoinositide 3-kinase beta in platelet aggregation and thromboxane A2 generation mediated by Gi signalling pathways. Biochem J 429(2):369\u2013377. https:\/\/doi.org\/10.1042\/bj20100166","journal-title":"Biochem J"},{"issue":"3","key":"2937_CR78","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1538-7836.2006.01789.x","volume":"4","author":"H Shankar","year":"2006","unstructured":"Shankar H, Garcia A, Prabhakar J, Kim S, Kunapuli SP (2006) P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1\/2 activation. J Thromb Haemost 4(3):638\u2013647. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01789.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2937_CR79","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2006-07-038158","volume":"109","author":"AJ Begonja","year":"2007","unstructured":"Begonja AJ, Geiger J, Rukoyatkina N, Rauchfuss S, Gambaryan S, Walter U (2007) Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP\/cGMP-dependent protein kinase. Blood 109(2):616\u2013618. https:\/\/doi.org\/10.1182\/blood-2006-07-038158","journal-title":"Blood"},{"issue":"8","key":"2937_CR80","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/09537104.2011.645924","volume":"23","author":"E Tournoij","year":"2012","unstructured":"Tournoij E, Koekman CA, Du VX, Roest M, Ruijtenbeek R, Moll FL, Akkerman JW (2012) The platelet P2Y12 receptor contributes to granule secretion through Ephrin A4 receptor. Platelets 23(8):617\u2013625. https:\/\/doi.org\/10.3109\/09537104.2011.645924","journal-title":"Platelets"},{"issue":"11","key":"2937_CR81","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1161\/01.ATV.20.11.e101","volume":"20","author":"M Cattaneo","year":"2000","unstructured":"Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML (2000) Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet \u2018primary secretion defect\u2019 are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 20(11):E101\u2013E106","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"2937_CR82","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/09537100500163226","volume":"16","author":"HM Judge","year":"2005","unstructured":"Judge HM, Buckland RJ, Holgate CE, Storey RF (2005) Glycoprotein IIb\/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses. Platelets 16(7):398\u2013407. https:\/\/doi.org\/10.1080\/09537100500163226","journal-title":"Platelets"},{"issue":"12","key":"2937_CR83","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/ATVBAHA.110.213702","volume":"30","author":"BH Rauch","year":"2010","unstructured":"Rauch BH, Rosenkranz AC, Ermler S, Bohm A, Driessen J, Fischer JW, Sugidachi A, Jakubowski JA, Schror K (2010) Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol 30(12):2434\u20132442. https:\/\/doi.org\/10.1161\/ATVBAHA.110.213702","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2937_CR84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.amjcard.2011.05.008","volume":"108","author":"CW Lee","year":"2011","unstructured":"Lee CW, Hwang I, Park CS, Lee H, Park DW, Kang SJ, Lee SW, Kim YH, Park SW, Park SJ (2011) Comparison of differential expression of P2Y(1)(2) receptor in culprit coronary plaques in patients with acute myocardial infarction versus stable angina pectoris. Am J Cardiol 108(6):799\u2013803. https:\/\/doi.org\/10.1016\/j.amjcard.2011.05.008","journal-title":"Am J Cardiol"},{"issue":"3","key":"2937_CR85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","volume":"6","author":"M Romano","year":"1997","unstructured":"Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bussolino F, Poli V, Ciliberto G, Mantovani A (1997) Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 6(3):315\u2013325","journal-title":"Immunity"},{"issue":"1","key":"2937_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2008.02.019","volume":"199","author":"I Ikonomidis","year":"2008","unstructured":"Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT (2008) Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease. Atherosclerosis 199(1):3\u201311. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.02.019","journal-title":"Atherosclerosis"},{"issue":"6","key":"2937_CR87","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nm.3866","volume":"21","author":"LS Shankman","year":"2015","unstructured":"Shankman LS, Gomez D, Cherepanova OA, Salmon M, Alencar GF, Haskins RM, Swiatlowska P, Newman AA, Greene ES, Straub AC, Isakson B, Randolph GJ, Owens GK (2015) KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med 21(6):628\u2013637. https:\/\/doi.org\/10.1038\/nm.3866","journal-title":"Nat Med"},{"issue":"1","key":"2937_CR88","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2015.01.006","volume":"239","author":"LR Johnston","year":"2015","unstructured":"Johnston LR, La Flamme AC, Larsen PD, Harding SA (2015) Prasugrel inhibits platelet-enhanced pro-inflammatory CD4+\u2009T cell responses in humans. Atherosclerosis 239(1):283\u2013286. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.006","journal-title":"Atherosclerosis"},{"issue":"6917","key":"2937_CR89","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P (2002) Inflammation in atherosclerosis. Nature 420(6917):868\u2013874. https:\/\/doi.org\/10.1038\/nature01323","journal-title":"Nature"},{"issue":"2","key":"2937_CR90","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1358863X07077462","volume":"12","author":"SR Steinhubl","year":"2007","unstructured":"Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Luscher TF (2007) Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 12(2):113\u2013122. https:\/\/doi.org\/10.1177\/1358863X07077462","journal-title":"Vasc Med"},{"issue":"6","key":"2937_CR91","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0002-9149(01)01813-6","volume":"88","author":"DP Chew","year":"2001","unstructured":"Chew DP, Bhatt DL, Robbins MA, Mukherjee D, Roffi M, Schneider JP, Topol EJ, Ellis SG (2001) Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein. Am J Cardiol 88(6):672\u2013674","journal-title":"Am J Cardiol"},{"issue":"11","key":"2937_CR92","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.jacc.2003.10.071","volume":"43","author":"Z Xiao","year":"2004","unstructured":"Xiao Z, Th\u00e9roux P (2004) Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 43(11):1982\u20131988. https:\/\/doi.org\/10.1016\/j.jacc.2003.10.071","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2937_CR93","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1023\/A:1023237029550","volume":"14","author":"J-K Cha","year":"2002","unstructured":"Cha J-K, Jeong M-H, Lee K-M, Bae H-R, Lim Y-J, Park KW, Cheon S-M (2002) Changes in platelet P-selectin and in plasma C-reactive protein in acute atherosclerotic ischemic stroke treated with a loading dose of clopidogrel. J Thromb Thrombolysis 14(2):145\u2013150","journal-title":"J Thromb Thrombolysis"},{"key":"2937_CR94","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.atherosclerosis.2018.05.053","volume":"275","author":"B Ganbaatar","year":"2018","unstructured":"Ganbaatar B, Fukuda D, Salim HM, Nishimoto S, Tanaka K, Higashikuni Y, Hirata Y, Yagi S, Soeki T, Sata M (2018) Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice. Atherosclerosis 275:124\u2013132. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.053","journal-title":"Atherosclerosis"},{"issue":"12","key":"2937_CR95","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/nn1805","volume":"9","author":"SE Haynes","year":"2006","unstructured":"Haynes SE, Hollopeter G, Yang G, Kurpius D, Dailey ME, Gan WB, Julius D (2006) The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 9(12):1512\u20131519. https:\/\/doi.org\/10.1038\/nn1805","journal-title":"Nat Neurosci"},{"issue":"1","key":"2937_CR96","doi-asserted-by":"publisher","first-page":"12088","DOI":"10.1038\/s41598-017-12205-w","volume":"7","author":"K Yamauchi","year":"2017","unstructured":"Yamauchi K, Imai T, Shimazawa M, Iwama T, Hara H (2017) Effects of ticagrelor in a mouse model of ischemic stroke. Sci Rep 7(1):12088. https:\/\/doi.org\/10.1038\/s41598-017-12205-w","journal-title":"Sci Rep"},{"issue":"6","key":"2937_CR97","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.thromres.2015.09.013","volume":"136","author":"A Tomizawa","year":"2015","unstructured":"Tomizawa A, Ohno K, Jakubowski JA, Mizuno M, Sugidachi A (2015) Prasugrel reduces ischaemic infarct volume and ameliorates neurological deficits in a non-human primate model of middle cerebral artery thrombosis. Thromb Res 136(6):1224\u20131230. https:\/\/doi.org\/10.1016\/j.thromres.2015.09.013","journal-title":"Thromb Res"},{"key":"2937_CR98","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejphar.2016.06.023","volume":"788","author":"A Sugidachi","year":"2016","unstructured":"Sugidachi A, Mizuno M, Ohno K, Jakubowski JA, Tomizawa A (2016) The active metabolite of prasugrel, R-138727, improves cerebral blood flow and reduces cerebral infarction and neurologic deficits in a non-human primate model of acute ischaemic stroke. Eur J Pharmacol 788:132\u2013139. https:\/\/doi.org\/10.1016\/j.ejphar.2016.06.023","journal-title":"Eur J Pharmacol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-018-2937-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-018-2937-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:02:46Z","timestamp":1775242966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-018-2937-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2937"],"URL":"https:\/\/doi.org\/10.1007\/s00018-018-2937-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"assertion":[{"value":"30 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"These experiments comply with the current laws of the country in which they were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}